BDBM249391 US10537571, Compound 100::US10912774, Compound 100::US9434697, 100::US9730931, Compound 100

SMILES COc1cc(OC)c(Cl)c(NC(=O)N(C)c2cc(Nc3ccccc3NC(=O)C=C)ncn2)c1Cl

InChI Key InChIKey=SNAPABPRVHZAGB-UHFFFAOYSA-N

Data  24 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 24 hits for monomerid = 249391   

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 2(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  4.18E+3nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 3(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  1.98E+3nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.01E+4nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Purified, recombinant FGFR4 was pre-incubated with 10 μM compound overnight at 4° C., or for 1 hour at room temperature. Following pre-incubatio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 2(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  4.18E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 3(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  1.98E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.01E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Purified, recombinant FGFR4 was pre-incubated with 10 μM compound overnight at 4° C., or for 1 hour at room temperature. Following pre-incubatio...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 2(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  4.18E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 3(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  1.98E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.01E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ ID NO:1) (20 μ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 4(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: <1nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.00E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 2(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  4.18E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 3(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50:  1.98E+3nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.01E+4nMAssay Description:Recombinant FGFR1 (2.5 nM), FGFR2 (1 nM), FGFR3 (5 nM), or FGFR4 (12 nM) (Invitrogen™) was prepared as a mixture with substrate KKKSPGEYVNIEFG (SEQ I...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent

TargetFibroblast growth factor receptor 1(Human)
Eisai R&D Management

US Patent
LigandPNGBDBM249391(US10537571, Compound 100 | US10912774, Compound 10...)
Affinity DataIC50: >1.00E+4nMpH: 7.5 T: 25°CAssay Description:Compounds were profiled for FGFR inhibition activity at Reaction Biology Corporation (Malvern, Pa.) with their Kinase HotSpot assay. See, Anastassiad...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent